TSHR-based chimeric antigen receptor T cell specifically deplete auto-reactive B lymphocytes for treatment of autoimmune thyroid disease, 2023, Huang+
Discussion in 'Other health news and research' started by EndME, Mar 13, 2024.
Discussion in 'Other health news and research' started by EndME, Mar 13, 2024.